Navigation Links
eHCGInjections Announces New Article; Doctor Contradicts FDA Take on HCG Injections for Weight Loss
Date:7/18/2013

LOS ANGELES, July 18, 2013 /PRNewswire-iReach/ -- The website HCG Injections (ehcginjections.com) aims to educate people on the safe use of Human Chorionic Gonadotropin (HCG) injections as part of a weight loss program. It is updated regularly with helpful articles on the topic and information on popular weight loss programs that incorporate HCG injections as part of their regimen. The site announced the addition of a new article to its library entitled, "Do HCG Injections Help with Weight Loss? A Physician's Opinion."

(Photo: http://photos.prnewswire.com/prnh/20130718/MN49410)

In the article, its author, Dr. Joseph Jamison, a specialist in nutrition and weight loss, takes a somewhat controversial stance on HCG injections that opposes what the FDA has communicated about their effectiveness. According to the article, although studies have shown that HCG injections can help people who've struggled to lose weight through other methods, they have only officially been approved by the FDA for the treatment of male and female infertility. In fact, the FDA issued a statement on HCG injections for weight loss claiming, "There is no supportive evidence that HCG is effective for weight loss."

Dr. Jamison is firm on his stance in the new article. "Using the natural hormone HCG, I have personally observed the physical transformation of men and women who could not otherwise lose weight," he writes. "My program combines HCG injections with a short term very low calorie diet, and my own observational studies have shown excellent weight loss and health improvement results."

For those who decide to try HCG injections for weight loss, the ehcginjections.com site offers and recommends Trim HCG Injections. The products come as part of a kit marketed by Trim Nutrition that includes everything people need to self-inject the HCG compound, and a complete day by day dietary guide to aid in getting people to their weight loss goal. Customers also get a free initial consultation with an account representative who can assist them in devising a custom weight loss program. Visitors to the site can also access Trim B12 Injections, an alternative choice for weight loss. The B12 supplement increases metabolism, boosts energy levels, decreases hunger pangs, and encourages normal sleep patterns – making dieters more rested and motivated to adhere to their weight loss journey.

About eHCGInjections.com

eHCGInjections.com is a site intended to educate people on the safe and effective use of HCG injections for weight loss. It is regularly updated with expert written articles, research and information on various weight loss programs that incorporate the use of HCG compounds. For more information, visit: http://ehcginjections.com

Media Contact: Jack Almeida, eHCGInjections.com, (949) 555-2861, admin@rocketfactor.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE eHCGInjections.com
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board meeting ... I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space ... membership in ARCS Alumni Hall of Fame . ASTER Labs is a ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
Breaking Biology Technology:
(Date:10/4/2017)...  GCE Solutions, a global clinical research organization (CRO), announces the ... on October 4, 2017. Shadow is designed to assist medical writers ... 0070 of the European Medicines Agency (EMA) in meeting the requirements ... ... ...
(Date:8/15/2017)... Aug. 15 2017   ivWatch LLC , a medical device ... therapy, today announced receipt of its ISO 13485 Certification, the global ... International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection of ... "This is an important milestone ...
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
Breaking Biology News(10 mins):